Stocks
DaVita Financial Statements (DVA) |
||||||||||
| DaVitasmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 21.02.2020 | 12.02.2021 | 11.02.2022 | 22.02.2023 | 14.02.2024 | 29.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 11 388 | 11 551 | 11 619 | 11 610 | 12 140 | 12 667 | |||
| Operating Income, bln rub | 1 643 | 1 695 | 1 797 | 1 339 | 1 603 | 1 930 | ||||
| EBITDA, bln rub | ? | 2 371 | 2 314 | 2 451 | 2 045 | 2 346 | 2 596 | |||
| Net profit, bln rub | ? | 811.0 | 773.6 | 978.5 | 768.2 | 691.5 | 827.7 | |||
| OCF, bln rub | ? | 2 072 | 1 979 | 1 931 | 1 565 | 2 059 | 1 965 | |||
| CAPEX, bln rub | ? | 766.5 | 674.5 | 641.5 | 603.4 | 568.0 | 543.8 | |||
| FCF, bln rub | ? | 1 306 | 1 304 | 1 289 | 961.1 | 1 491 | 1 421 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 1 718 | 1 878 | 1 876 | 2 088 | 1 474 | 1 712 | ||||
| Cost of production, bln rub | 7 914 | 7 989 | 7 972 | 8 210 | 8 320 | 8 882 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 443.8 | 304.1 | 285.3 | 357.0 | 398.6 | 427.9 | ||||
| Assets, bln rub | 17 311 | 16 989 | 17 121 | 16 928 | 17 619 | 17 504 | ||||
| Net Assets, bln rub | ? | 2 133 | 1 384 | 755.5 | 712.3 | 1 056 | 386.7 | |||
| Debt, bln rub | 11 176 | 11 194 | 11 975 | 11 822 | 11 116 | 12 198 | ||||
| Cash, bln rub | 1 114 | 345.1 | 484.2 | 321.8 | 391.7 | 1 092 | ||||
| Net debt, bln rub | 10 062 | 10 849 | 11 491 | 11 501 | 10 725 | 11 106 | ||||
| Ordinary share price, rub | 75.0 | 117.4 | 113.8 | 74.7 | 104.8 | 77.9 | ||||
| Number of ordinary shares, mln | 153.2 | 119.8 | 105.2 | 93.0 | 90.8 | 83.7 | ||||
| Market cap, bln rub | 11 493 | 14 064 | 11 971 | 6 944 | 9 511 | 6 519 | ||||
| EV, bln rub | ? | 21 555 | 24 913 | 23 462 | 18 444 | 20 236 | 17 625 | |||
| Book value, bln rub | -4 790 | -5 702 | -6 468 | -6 547 | -6 260 | -7 039 | ||||
| EPS, rub | ? | 5.29 | 6.46 | 9.30 | 8.26 | 7.62 | 9.89 | |||
| FCF/share, rub | 8.52 | 10.9 | 12.3 | 10.3 | 16.4 | 17.0 | ||||
| BV/share, rub | -31.3 | -47.6 | -61.5 | -70.4 | -68.9 | -84.1 | ||||
| EBITDA margin, % | ? | 20.8% | 20.0% | 21.1% | 17.6% | 19.3% | 20.5% | |||
| Net margin, % | ? | 7.12% | 6.70% | 8.42% | 6.62% | 5.70% | 6.53% | |||
| FCF yield, % | ? | 11.4% | 9.28% | 10.8% | 13.8% | 15.7% | 21.8% | |||
| ROE, % | ? | 38.0% | 55.9% | 129.5% | 107.8% | 65.5% | 214.0% | |||
| ROA, % | ? | 4.68% | 4.55% | 5.71% | 4.54% | 3.92% | 4.73% | |||
| P/E | ? | 14.2 | 18.2 | 12.2 | 9.04 | 13.8 | 7.88 | |||
| P/FCF | 8.80 | 10.8 | 9.28 | 7.22 | 6.38 | 4.59 | ||||
| P/S | ? | 1.01 | 1.22 | 1.03 | 0.60 | 0.78 | 0.51 | |||
| P/BV | ? | -2.40 | -2.47 | -1.85 | -1.06 | -1.52 | -0.93 | |||
| EV/EBITDA | ? | 9.09 | 10.8 | 9.57 | 9.02 | 8.62 | 6.79 | |||
| Debt/EBITDA | 4.24 | 4.69 | 4.69 | 5.62 | 4.57 | 4.28 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 6.73% | 5.84% | 5.52% | 5.20% | 4.68% | 4.29% | ||||
| DaVita shareholders | ||||||||||
